ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Biotech Firm Raises £4.5M for North American Expansion

EDINBURGH, United Kingdom, Nov. 19, 2025 (GLOBE NEWSWIRE) -- A pioneering biotech company using fungal technology to enhance tree growth and survival rates is set to expand into North America after raising $5.5 million (£4.5 million) in fresh investment.

Rhizocore Technologies’ flagship product, RhizoPellets™, helps trees survive planting and grow stronger and faster by pairing them with specific ectomycorrhizal (ECM) fungi. Drawing on one of the world's largest living fungal libraries, Rhizocore selects the precise, high-performance species suited to each planting site. These fungi form a symbiotic network with tree roots, helping them absorb more nutrients and water.

Headquartered just outside Edinburgh, Scotland, Rhizocore will now scale operations to meet expected demand across the U.S., where more than 1.4 billion trees are planted annually. The new funding will also support a major upgrade at the company’s Scottish facility to fulfill orders across Europe.

The funding round was led by The First Thirty, a specialist investor focused on soil health technologies. Additional support came from Scottish Enterprise and several existing clients, including the Grosvenor Estate, one of the UK’s largest landowners. Additional investors in the round are Sand River, Generation-Re (Regenerative Agriculture Syndicate), Kibo Invest, John Thomson, and Old College Capital.

Dr. Toby Parkes, founder of Rhizocore, said:

“Our expansion into the U.S. is about more than scale, it's about impact. North America faces significant challenges to its forestry sector, including reduced milling capacity and increasing amounts of droughts and wildfires.

“We believe our fungal technology can deliver both ecological and financial returns at scale, by increasing tree survival and early growth rates, enabling the US forestry sector to continue to provide returns well into the future.”

Plantings using RhizoPellets™ across numerous sites and involving major industry partners have delivered unprecedented results. Forestry and Land Scotland (FLS) found treated trees have shown a 97% survival rate compared to just 78% for untreated saplings, a relative 25% improvement in survival rate. And at a site owned by Trees for Life, one of the UK's leading native woodland restoration charities, saplings grew thirteen times faster than control and fertilised trees after 12 months.

Rhizocore is currently active across more than 100 sites in the UK, working with clients ranging from large-scale forest managers to conservation charities. The investment will allow the company to increase supply to meet future demand with existing customers already having purchased 100% of planned 2025/26 capacity.

Antony Yousefian, General Partner at The First Thirty, said:

“Our thesis is simple: soil health is foundational to planetary health. Rhizocore fits perfectly. We invest in technologies that unlock the economic value of soil biology, and this technology proves that boosting soil ecosystems isn’t just good for the planet, it’s also a strong driver of financial returns.”

Issued by Holyrood PR on behalf of Rhizocore Technologies. Please contact info@holyroodpr.co.uk or +44 131 561 2244.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/64149064-9002-4784-9e48-03c9214088f1


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.